Gengfeng Fu
Overview
Explore the profile of Gengfeng Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ye J, Dong Y, Lan Y, Chen J, Zhou Y, Liu J, et al.
J Infect Dis
. 2024 Aug;
230(6):1410-1421.
PMID: 39189826
Background: National treatment guidelines of China evolving necessitates population-level surveillance of transmitted drug resistance (TDR) to inform or update HIV treatment strategies. Methods: We analyzed the demographic, clinical, and virologic...
2.
Ye J, Lan Y, Wang J, Feng Y, Lin Y, Zhou Y, et al.
J Infect Dis
. 2024 Aug;
230(5):1202-1214.
PMID: 39186695
Background: In 2016, China has implemented the World Health Organization's "treat all" policy. We aimed to assess the impact of significant improvements in the 95-95-95 targets on population-level human immunodeficiency...
3.
Zhang H, Li Z, Li P, Fu G, Zhang D, Cheng X, et al.
AIDS Care
. 2024 Mar;
36(sup1):15-23.
PMID: 38526977
Mental health problems leads to serious disease burden among people living with HIV/AIDS (PLHIV). The study aimed at measuring the mental disorders-caused burden of disease based on PLHIV in mainland...
4.
HIV Services Uptake Among People Living with HIV in Jiangsu Province, China: A Cross-Sectional Study
Ai W, Shi L, Tan R, Wu D, Ong J, Qiu T, et al.
AIDS Behav
. 2024 Mar;
28(6):1936-1946.
PMID: 38493282
Healthcare disparities are common among people living with HIV (PLWH) in China and likely impact access to HIV services. This study aimed to assess the current status of access to...
5.
Liu S, Yuan D, Zhou Y, Fu G, Wang B
Ann Med
. 2023 Dec;
55(2):2288309.
PMID: 38065681
Evaluate the profiles of post-exposure prophylaxis (PEP) adherence, adverse drug reactions (ADRs), and discontinuation associated with ADRs to provide information for further PEP program improvement and increase adherence to PEP....
6.
Wu X, Wu G, Ma P, Wang R, Li L, Chen Y, et al.
Nat Commun
. 2023 Sep;
14(1):5334.
PMID: 37660054
Despite the proven virological advantages, there remains some controversy regarding whether first-line integrase strand transfer inhibitors (INSTIs)-based antiretroviral therapy (ART) contributes to reducing mortality of people living with HIV (PLHIV)...
7.
Zhang Y, Li J, Xie Y, Wu D, Ong J, Marley G, et al.
Nat Med
. 2023 Aug;
29(9):2241-2247.
PMID: 37640859
Pay-it-forward incentives involve having a person receive a free test with community-generated messages and then asking if those who received a free test would like to donate money to support...
8.
Wu X, Wu G, Ma P, Wang R, Li L, Sun Y, et al.
Infect Dis Poverty
. 2023 Aug;
12(1):73.
PMID: 37580822
Background: In 2003, China implemented free antiretroviral therapy (ART) for people living with HIV (PLHIV), establishing an eligibility threshold of CD4 < 200 cells/μl. Subsequently, the entry criteria were revised...
9.
Ai W, Fan C, Marley G, Tan R, Wu D, Ong J, et al.
HIV Med
. 2023 Jul;
24(11):1093-1105.
PMID: 37407253
Background: This review aims to assess the status of healthcare disparities among people living with HIV (PLWH) in China and summarize the factors that drive them. Methods: We searched PubMed,...
10.
Wu Z, Fu G, Wen Q, Wang Z, Shi L, Qiu B, et al.
Infect Drug Resist
. 2023 Jun;
16:4039-4052.
PMID: 37383602
Purpose: Pulmonary tuberculosis (PTB) is a severe chronic communicable disease that causes a heavy disease burden in China. Human Immunodeficiency Virus (HIV) and PTB coinfection dramatically increases the risk of...